Antibodies to the Central Conserved Region of Respiratory Syncytial Virus (RSV) G Protein Block RSV G Protein CX3C-CX3CR1 Binding and Cross-Neutralize RSV A and B Strains-Reference-Cited by-同舟云学术

Antibodies to the Central Conserved Region of Respiratory Syncytial Virus (RSV) G Protein Block RSV G Protein CX3C-CX3CR1 Binding and Cross-Neutralize RSV A and B Strains

Published:2012-05-02 Issue: Volume: Page:120502120244005
ISSN:0882-8245
Container-title:Viral Immunology
language:en
Short-container-title:Viral Immunology

Author:

Choi Youngjoo,Mason Caleb S.,Jones Les P.,Crabtree Jackelyn,Jorquera Patricia A.,Tripp Ralph A.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Molecular Medicine,Immunology

Reference68 articles.

1. T280M Variation of the CX3C Receptor Gene Is Associated With Increased Risk for Severe Respiratory Syncytial Virus Bronchiolitis

2. Antigenic Characterization of Respiratory Syncytial Virus Strains with Monoclonal Antibodies

3. Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells

4. Peptides as tools and drugs for immunotherapies

5. Immunogenicity of Purified F Glycoprotein of Respiratory Syncytial Virus: Clinical and Immune Responses to Subsequent Natural Infection in Children

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus;Viruses;2024-05-24

2. Monoclonal antibodies targeting sites in respiratory syncytial virus attachment G protein provide protection against RSV-A and RSV-B in mice;Nature Communications;2024-04-04

3. Neutralizing antibodies to block viral entry and for identification of entry inhibitors;Antiviral Research;2024-04

4. Structural basis for respiratory syncytial virus and human metapneumovirus neutralization;Current Opinion in Virology;2023-08

5. Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine;Frontiers in Immunology;2023-06-29